Tocagen tocagen.com


Public list: BIO 2016 (619) Smart Money VCs (6326) Synthetic Biology (153) Pharma Startups (6570) Cancer Therapeutics (1180)

Tocagen is a clinical-stage biopharmaceutical company pursuing the discovery, development, and commercialization of products for the treatment of cancer. Tocagen is initially focusing on treatments for patients with advanced cancer for whom no adequate treatment currently exists. The Company believes that selective cancer immunotherapies represent an important opportunity for treating cancers because such therapeutics selectively activate the immune system against the tumor both locally and syst...Show all

Tocagen is a clinical-stage biopharmaceutical company pursuing the discovery, development, and commercialization of products for the treatment of cancer. Tocagen is initially focusing on treatments for patients with advanced cancer for whom no adequa...Show all

Company (IPO / Went public)

Phone: 858-412-8400

Fax:

3030 Bunker Hill Street
Suite 230
San Diego, 92109
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Tocagen $124.3M Apr 13, 2017
GlobeImmune $162.5M Jul 2, 2014
MacroGenics $252.1M Oct 10, 2013
See all 16 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Tocagen Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 6 investors

Competitors

Company Status Description Investors
See all 16 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Formulations of 5-fluorocytosine and uses thereof Feb 07, 2018 Oct 22, 2019 Patent
Recombinant vectors Aug 08, 2017 Sep 10, 2019 Patent
Producer cells for replication competent retroviral vectors Jun 17, 2010 Jun 11, 2019 Patent
Gene therapy vectors and cytosine deaminases May 09, 2014 Jul 31, 2018 Patent
Formulations of 5-fluorocytosine and uses thereof Apr 22, 2016 Feb 13, 2018 Patent
See all 22 patents